MX2009005351A - Compuestos utiles para tratar trastornos neurodegenerativos. - Google Patents
Compuestos utiles para tratar trastornos neurodegenerativos.Info
- Publication number
- MX2009005351A MX2009005351A MX2009005351A MX2009005351A MX2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A MX 2009005351 A MX2009005351 A MX 2009005351A
- Authority
- MX
- Mexico
- Prior art keywords
- compounds useful
- neurodegenerative disorders
- treating neurodegenerative
- treating
- lessening
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 3
- 208000015122 neurodegenerative disease Diseases 0.000 title abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D335/00—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
- C07D335/04—Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
- A01N43/34—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom
- A01N43/40—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings
- A01N43/42—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one nitrogen atom as the only ring hetero atom six-membered rings condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Diabetes (AREA)
- Psychology (AREA)
- Ophthalmology & Optometry (AREA)
- Pest Control & Pesticides (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Agronomy & Crop Science (AREA)
- Wood Science & Technology (AREA)
- Dentistry (AREA)
- Plant Pathology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Como describe en la presente, la presente invención proporciona las compuestos útiles para tratar o disminuir la severidad del trastorno neurodegenerativo. La presente invención también proporciona los métodos para tratar o disminuir la severidad de tales trastornos, en donde el método comprende administrar a una paciente un compuesto de la presente invención, o la composición del mismo. El método es útil para tratar o disminuir la severidad de, por ejemplo, la enfermedad de Alzheimer.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2006/044880 WO2008063165A1 (en) | 2006-11-20 | 2006-11-20 | Compounds useful for treating neurodegenerative disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2009005351A true MX2009005351A (es) | 2009-06-08 |
Family
ID=39429980
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2009005351A MX2009005351A (es) | 2006-11-20 | 2006-11-20 | Compuestos utiles para tratar trastornos neurodegenerativos. |
Country Status (10)
| Country | Link |
|---|---|
| EP (1) | EP2073637A4 (es) |
| JP (1) | JP2010510309A (es) |
| KR (1) | KR20090087075A (es) |
| CN (1) | CN101610673A (es) |
| AU (1) | AU2006350960B2 (es) |
| BR (1) | BRPI0622138A2 (es) |
| CA (1) | CA2670276A1 (es) |
| IL (1) | IL198856A0 (es) |
| MX (1) | MX2009005351A (es) |
| WO (1) | WO2008063165A1 (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI433674B (zh) | 2006-12-28 | 2014-04-11 | Infinity Discovery Inc | 環杷明（ｃｙｃｌｏｐａｍｉｎｅ）類似物類 |
| US7990394B2 (en) | 2007-05-25 | 2011-08-02 | Google Inc. | Viewing and navigating within panoramic images, and applications thereof |
| JP6141015B2 (ja) | 2009-08-05 | 2017-06-07 | インフィニティ ファーマスーティカルズ、インク． | シクロパミン類似体の酵素によるアミノ基転移 |
| US9376447B2 (en) | 2010-09-14 | 2016-06-28 | Infinity Pharmaceuticals, Inc. | Transfer hydrogenation of cyclopamine analogs |
| HRP20251395T1 (hr) | 2015-06-04 | 2026-02-13 | Sol-Gel Technologies Ltd. | Topikalne formulacije za isporuku spojeva inhibitora hedgehog signalnog puta i njihova uporaba |
| US10217283B2 (en) | 2015-12-17 | 2019-02-26 | Google Llc | Navigation through multidimensional images spaces |
| US10245091B2 (en) | 2015-12-30 | 2019-04-02 | Exsomed Holding Company, Llc | Dip fusion spike screw |
| CN107281206A (zh) * | 2016-03-30 | 2017-10-24 | 南京惠宝生物医药有限公司 | 黑升麻苷在制备防治老年性痴呆药物中的应用 |
| KR102120376B1 (ko) * | 2018-05-28 | 2020-06-09 | 한국과학기술연구원 | 승마 추출물, 이의 분획물 또는 승마에서 유래된 화합물을 유효성분으로 포함하는 퇴행성 뇌질환의 예방 또는 치료용 조성물 |
| CN109528738A (zh) * | 2018-12-24 | 2019-03-29 | 陕西师范大学 | 甘草酸在制备促进髓鞘再生抑制神经炎症药物的应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030060425A1 (en) * | 1998-11-24 | 2003-03-27 | Ahlem Clarence N. | Immune modulation method using steroid compounds |
| GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
| CA2479249A1 (en) * | 2002-03-15 | 2003-09-25 | Samaritan Pharmaceuticals, Inc. | Neuroprotective spirostenol pharmaceutical compositions |
| CN101223185A (zh) * | 2005-05-17 | 2008-07-16 | 萨托里医药公司 | 用于治疗神经变性障碍的化合物 |
-
2006
- 2006-11-20 CA CA002670276A patent/CA2670276A1/en not_active Abandoned
- 2006-11-20 JP JP2009538376A patent/JP2010510309A/ja active Pending
- 2006-11-20 CN CNA2006800568742A patent/CN101610673A/zh active Pending
- 2006-11-20 WO PCT/US2006/044880 patent/WO2008063165A1/en not_active Ceased
- 2006-11-20 MX MX2009005351A patent/MX2009005351A/es not_active Application Discontinuation
- 2006-11-20 AU AU2006350960A patent/AU2006350960B2/en not_active Expired - Fee Related
- 2006-11-20 EP EP06838050A patent/EP2073637A4/en not_active Withdrawn
- 2006-11-20 KR KR1020097012727A patent/KR20090087075A/ko not_active Ceased
- 2006-11-20 BR BRPI0622138-6A patent/BRPI0622138A2/pt not_active IP Right Cessation
-
2009
- 2009-05-20 IL IL198856A patent/IL198856A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20090087075A (ko) | 2009-08-14 |
| EP2073637A1 (en) | 2009-07-01 |
| AU2006350960B2 (en) | 2013-09-12 |
| AU2006350960A1 (en) | 2008-05-29 |
| WO2008063165A1 (en) | 2008-05-29 |
| EP2073637A4 (en) | 2011-12-28 |
| BRPI0622138A2 (pt) | 2011-12-27 |
| IL198856A0 (en) | 2010-02-17 |
| CN101610673A (zh) | 2009-12-23 |
| JP2010510309A (ja) | 2010-04-02 |
| CA2670276A1 (en) | 2008-05-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008130449A3 (en) | Modulators of amyloid-beta production | |
| EA200971050A1 (ru) | Способы лечения и предупреждения нейродегенеративных заболеваний и нарушений | |
| MXPA05012680A (es) | Indoles novedosos de 3-azufre sustituidos. | |
| WO2009127642A3 (en) | Use of lrrk2 inhibitors for neurodegenerative diseases | |
| TW200510303A (en) | Novel compounds | |
| TW200612892A (en) | Novel compounds | |
| MX2007012374A (es) | Metodos y composiciones para el tratamiento de condiciones relacionadas con cns. | |
| WO2007138282A3 (en) | Bi-aryl or aryl-heteroaryl substituted indoles | |
| WO2009025785A3 (en) | Cb2 receptor ligands for the treatment of pain | |
| WO2010075280A3 (en) | Coumarin-based compounds for the treatment of alzheimer's disease and cancer | |
| DE502004003249D1 (en) | (s)-2-n-propylamino-5-hydroxytetralin als d3-agonistisches therapeutikum | |
| ATE543494T1 (de) | Griseofulvin-analoga zur behandlung von krebs durch hemmung von zentrosomaler clusterbildung | |
| MX2009003981A (es) | Agentes moduladores del receptor de calcio. | |
| MX368459B (es) | Nuevas composiciones para prevenir y/o tratar trastornos degenerativos del sistema nervioso central. | |
| TW200745003A (en) | Novel compounds | |
| EP2542085A4 (en) | COMPOUNDS FOR THE TREATMENT OF NEURODEEGENERATIVE DISORDER | |
| WO2008136863A3 (en) | Synthesis of compounds useful as modulators of amyloid-beta production | |
| EA201001586A1 (ru) | Соединения и композиции в качестве ингибиторов itpkb | |
| WO2007052023A3 (en) | Novel compounds | |
| IL185410A0 (en) | Use of 2-(2-nitro-4-trifluoromethylbenzoyl)-1,3-cyclohexanedione in the treatment of parkinson's disease | |
| PT1778837E (pt) | Tratamento de doenças neurodegenerativas por utilização de inibidores de scd4 | |
| MX2007011847A (es) | Derivados de pirimidindiona como antagonistas del receptor de procineticina 2. | |
| TW200642690A (en) | Composition for treating central nervous system disorders | |
| TW200602297A (en) | Sulfonamide compounds for the treatment of neurodegenerative disorders | |
| TW200744577A (en) | Method for treating osteoarthritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |